Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Winter;25(1):4-10.
Epub 2016 Feb 1.

Update on the Use of SSRIs and SNRIs with Children and Adolescents in Clinical Practice

Affiliations

Update on the Use of SSRIs and SNRIs with Children and Adolescents in Clinical Practice

E Jane Garland et al. J Can Acad Child Adolesc Psychiatry. 2016 Winter.
No abstract available

PubMed Disclaimer

References

    1. Atkinson SD, Prakash A, Zhang Q, Pangallo BA, Bangs ME, Emslie GJ, March JS. A double-blind efficacy and safety study of duloxetine flexible dosing in children and adolescents with major depressive disorder. Journal of Child and Adolescent Psychopharmacology. 2014;24(4):180–189. doi: 10.1089/cap.2013.0146. - DOI - PubMed
    1. Brent D, Emslie G, Clarke G, Wagner KD, Asarnow JR, Keller, Zelazny J. Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: The TORDIA randomized controlled trial. Journal of the American Medical Association. 2008;299(8):901–913. doi: 10.1001/jama.299.8.901. - DOI - PMC - PubMed
    1. Bridge JA, Iyengar S, Salary CB, Barbe RP, Birmaher B, Pincus HA, Brent DA. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: A meta-analysis of randomized controlled trials. Journal of the American Medical Association. 2007;297(15):1683–1696. - PubMed
    1. Bridge JA, Birmaher B, Iyengar S, Barbe RP, Brent DA. Placebo response in randomized controlled trials of antidepressants for pediatric major depressive disorder. American Journal of Psychiatry. 2009;166(1):42–49. doi: 10.1176/appi.ajp.2008.08020247. - DOI - PubMed
    1. Canadian Agency for Drugs and Technology in Health (CADTH) Rapid Response Report: Summary with Critical Appraisal. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2015. Second Generation Antidepressants for Pediatric Patients with Major Depressive Disorder and Anxiety Disorder: A Review of the Clinical Effectiveness and Safety. Retrieved from https://www.cadth.ca/second-generation-antidepressants-pediatric-patient.... - PubMed

LinkOut - more resources